Together with serum AFP, plasma exosomal miR-21-5p and miR-92a-3p could be used as potential biomarkers for HCC diagnosis in patients with LC subjected to screening and surveillance. The gene discussed is AFP; the disease is laryngotracheoesophageal cleft.